Research Topics
| Carrie N KlabundeSummaryAffiliation: National Institutes of Health Country: USA Publications
| Collaborators
|
Detail Information
Publications
Lung cancer screening practices of primary care physicians: results from a national surveyCarrie N Klabunde
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland
Ann Fam Med 10:102-10. 2012..Primary care physicians and patients need more information about lung cancer screening's evidence base, guidelines, potential harms, and costs to avert inappropriate ordering...- Improving colorectal cancer screening through research in primary care settingsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892-7344, USA
Med Care 46:S1-4. 2008 - Improving colorectal cancer screening in primary care practice: innovative strategies and future directionsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, EPN 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
J Gen Intern Med 22:1195-205. 2007..Active engagement and support of practices are essential for the enormous potential of CRC screening to be realized... - Data sources for measuring comorbidity: a comparison of hospital records and medicare claims for cancer patientsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
Med Care 44:921-8. 2006..Identifying appropriate comorbidity data sources is a key consideration in health services and outcomes research... - Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007Carrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Am J Prev Med 37:8-16. 2009..S. This study describes the CRC screening recommendations and practices of U.S. physicians and compares them to findings from a 1999-2000 national provider survey... - The role of primary care physicians in cancer careCarrie N Klabunde
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, EPN 4005 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
J Gen Intern Med 24:1029-36. 2009..The demand for oncology services in the United States (US) is increasing, whereas a shortage of oncologists looms. There is the need for a better understanding of the involvement of primary care physicians (PCPs) in cancer care... - U.S. primary care physicians' lung cancer screening beliefs and recommendationsCarrie N Klabunde
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Am J Prev Med 39:411-20. 2010..Nevertheless, lung cancer screening tests are available in the U.S., and primary care physicians (PCPs) may have a role in recommending them to patients... - Trends in colorectal cancer test use among vulnerable populations in the United StatesCarrie N Klabunde
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 20:1611-21. 2011..This study examines recent national trends in CRC test use, including among vulnerable populations... - A population-based assessment of specialty physician involvement in cancer clinical trialsCarrie N Klabunde
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 103:384-97. 2011.... - Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancerVickie L Shavers
Applied Research Program, Health Services and Economics Branch, National Cancer Institute, Bethesda, MD 20892 7344, USA
Med Care 42:239-50. 2004..We examine the type and intensity of medical monitoring received by African American, Hispanic, and white patients with prostate cancer managed with "watchful waiting" in fee-for-service systems... - A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patientsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892 7344, USA
Ann Epidemiol 17:584-90. 2007.... - Cancer, comorbidities, and health-related quality of life of older adultsAshley Wilder Smith
National Cancer Institute NCI, Bethesda, MD 20892 7344, USA
Health Care Financ Rev 29:41-56. 2008..Negative associations were most pronounced in those with two or more comorbidities and in those diagnosed with cancer within the past year... - A national survey of primary care physicians' colorectal cancer screening recommendations and practicesCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, MD 20892, USA
Prev Med 36:352-62. 2003.... - Health plan policies and programs for colorectal cancer screening: a national profileCarrie N Klabunde
Division of Cancer Control and Population Sciences, National Cancer Institute NCI, Executive Plaza North Room 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
Am J Manag Care 10:273-9. 2004..A consensus has emerged that average-risk adults 50 years of age or older should be screened for colorectal cancer (CRC)... - Barriers to colorectal cancer screening among Medicare consumersCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Am J Prev Med 30:313-9. 2006..Few studies have examined lack of physician recommendation and other reasons for under-utilization of colorectal cancer (CRC) screening in the Medicare population... - Patterns of colorectal cancer screening uptake among men and women in the United StatesHelen I Meissner
Applied Cancer Screening Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7331, USA
Cancer Epidemiol Biomarkers Prev 15:389-94. 2006..The purpose of this report is to examine (a) gender-specific correlates of colorectal cancer test use using recent national data from 2003 and (b) patterns of colorectal cancer screening by gender and test modality over time... - Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adultsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 43:939-44. 2005..Barriers to colorectal cancer (CRC) screening are not well understood... - Physicians' use of nonphysician healthcare providers for colorectal cancer screeningLeah B Sansbury
Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Bethesda, Maryland 20892-7344, USA
Am J Prev Med 25:179-86. 2003..However, physician beliefs about the ability of nurse practitioners and physician assistants to perform flexible sigmoidoscopy are a potential barrier to increasing the involvement of nonphysician providers in CRC screening delivery... - Are physicians' recommendations for colorectal cancer screening guideline-consistent?K Robin Yabroff
HealthServices and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892 7344, USA
J Gen Intern Med 26:177-84. 2011..The objective of this study was to explore potentially modifiable physician and practice factors associated with guideline-consistent recommendations for the menu of CRC screening modalities... - Colorectal cancer screening with double-contrast barium enema: a national survey of diagnostic radiologistsCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, National Cancer Institute, Executive Plaza North, Rm. 4005, 6130 Executive Blvd, Bethesda, MD 20892-7344, USA
AJR Am J Roentgenol 179:1419-27. 2002..Because primary care physicians view double-contrast barium enema less positively than do radiologists, radiologists' expectations for an increased volume of double-contrast barium enemas over the next few years may not be realized... - Comparing colorectal cancer screening and immunization status in older americansCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Am J Prev Med 33:1-8. 2007.... - Measuring complications of cancer treatment using the SEER-Medicare dataArnold L Potosky
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 40:IV-62-8. 2002..One category of outcomes amenable to research using Medicare claims is complications of cancer treatments: the unintentional, adverse side effects or sequelae of interventions used to treat or palliate cancer patients... - Adverse events after outpatient colonoscopy in the Medicare populationJoan L Warren
National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Ann Intern Med 150:849-57, W152. 2009..Although use of colonoscopy has increased substantially among elderly Medicare beneficiaries, no one has described colonoscopy-related adverse events in a representative sample of Medicare patients... - Do patients consistently report comorbid conditions over time?: results from the prostate cancer outcomes studyCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 43:391-400. 2005..Comorbidity is an important dimension of patient health status. However, limited attention has been given to assessing the reliability of patient-reported data on comorbid conditions... - Utility of the SEER-Medicare data to identify chemotherapy useJoan L Warren
Applied Research Program, National Cancer Institute, Bethesda, Maryland 20892 7344
Med Care 40:IV-55-61. 2002..However, the validity and completeness of these data as a source of information has not been established... - Assessing comorbidity using claims data: an overviewCarrie N Klabunde
Health Services and Economics Branch, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 40:IV-26-35. 2002..The assessment of comorbidity using claims data is a complex and evolving area of investigation... - Breast cancer screening beliefs, recommendations and practices: primary care physicians in the United StatesHelen I Meissner
Office of Behavioral and Social Sciences Research, National Institutes of Health, Bethesda, Maryland, USA
Cancer 117:3101-11. 2011..Primary care physicians (PCPs) play a key role in breast cancer screening, yet no current data exist regarding PCP practices... - Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute Survey of Colorectal Cancer Screening PracticesMartin L Brown
Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Am J Med 115:129-33. 2003..The purpose of this study was to provide nationally representative data on endoscopic resources at the provider level... - Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomyPauline A Mysliwiec
National Cancer Institute, Bethesda, Maryland 20892-7344, USA
Ann Intern Med 141:264-71. 2004..These results suggest unnecessary demand for endoscopic resources... - Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancerLinda C Harlan
Applied Research Program, National Cancer Institute, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892, USA
J Cancer Surviv 3:89-98. 2009..To describe comorbidities in breast cancer patients at diagnosis and examine factors associated with self-reported comorbidities 30 months post-diagnosis... - Physician over-recommendation of mammography for terminally ill womenCorinne R Leach
Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Cancer 118:27-37. 2012..Identifying characteristics of physicians who recommend mammography for terminally ill women can help guide efforts to minimize patient risks and make better use of health care resources... - Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancerVickie L Shavers
Applied Research Program National Cancer Institute, Bethesda, MD 20892, USA
J Gen Intern Med 19:146-55. 2004.... - Population-based survivorship research using cancer registries: a study of non-Hodgkin's lymphoma survivorsNeeraj K Arora
Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Blvd, MSC 7344, Executive Plaza North 4005, Bethesda, MD 20892 7344, USA
J Cancer Surviv 1:49-63. 2007..Drawing upon experiences from a study of survivors of non-Hodgkin's Lymphoma (NHL), we discuss conceptual and methodological challenges to and opportunities for conducting population-based survivorship research using cancer registries... - Physician use of genetic testing for cancer susceptibility: results of a national surveyLouise Wideroff
National Cancer Institute, Division of Cancer Control and Population Sciences, Bethesda, Maryland 20892 7344, USA
Cancer Epidemiol Biomarkers Prev 12:295-303. 2003..39; 95% CI, 0.23-0.66%). These findings underscore the importance of establishing effective clinical approaches to test use and promoting physician education to facilitate communication with patients about cancer genetics... - Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countriesCarrie N Klabunde
National Cancer Institute, Health Services and Economics Branch, Bethesda, MD 20892 7344, USA
Int J Qual Health Care 14:449-61. 2002.... - Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly populationJoan L Warren
Applied Research Program, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 40:IV-3-18. 2002..The use of this database to study cancer screening, treatment, outcomes, and costs has grown in recent years... - Systems strategies to support cancer screening in U.S. primary care practiceK Robin Yabroff
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland, USA
Cancer Epidemiol Biomarkers Prev 20:2471-9. 2011..Although systems strategies are effective in improving health care delivery, little is known about their use for cancer screening in U.S. primary care practice... - Physician recommendations for follow-up of positive fecal occult blood testsK Robin Yabroff
National Cancer Institute, USA
Med Care Res Rev 62:79-110. 2005..Development of interventions to improve recommendations of CDE is an important area for future research... - Measuring breast, colorectal, and prostate cancer screening with medicare claims dataJean L Freeman
Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas 77555 0460, USA
Med Care 40:IV-36-42. 2002..Medicare claims may be a useful source of data when screening older populations, but they are limited in terms of completeness and the ability to distinguish screening tests from those provided for diagnosis or surveillance... - Use of SEER-Medicare data for measuring cancer surgeryGregory S Cooper
Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA
Med Care 40:IV-43-8. 2002..The accuracy and completeness of the SEER-Medicare data for measuring cancer-related therapy have not been extensively evaluated... - Studying radiation therapy using SEER-Medicare-linked dataBeth A Virnig
Division of Health Services Research and Policy, University of Minnesota, Minneapolis, Minnesota 55455, USA
Med Care 40:IV-49-54. 2002..Numerous studies have used the SEER or Medicare data to assess the use of radiation therapy. However, the completeness of these data has not been evaluated... - Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plansGerald F Riley
Office of Research, Development, and Information, Centers for Medicare and Medicaid Services, Baltimore, Maryland 21244, USA
Med Care 46:1108-15. 2008..To compare the Medicare managed care (MC) and fee-for-service (FFS) sectors on stage at diagnosis and treatment patterns for prostate, female breast, and colorectal cancers, and to examine patterns across MC plans... - Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurementLaura-Mae Baldwin
Department of Family Medicine, University of Washington, Seattle, Washington 98105-6099, USA
Med Care 40:IV-82-95. 2002.... - Are there gender differences in colorectal cancer test use prevalence and correlates?Amy McQueen
Center for Health Promotion and Prevention Research, University of Texas School of Public Health, Houston, 77030, USA
Cancer Epidemiol Biomarkers Prev 15:782-91. 2006..Such differences, if confirmed in future studies, may inform the use of gender-specific intervention strategies or messages to increase colorectal cancer test use... - A national survey of primary care physicians' methods for screening for fecal occult bloodMarion R Nadel
Centers for Disease Control and Prevention and American Cancer Society, Atlanta, Georgia 30341 3717, ISA
Ann Intern Med 142:86-94. 2005..Although the test is simple, implementation requires adherence to specific techniques of testing and follow-up of abnormal results... - A population-based study of colorectal cancer test use: results from the 2001 California Health Interview SurveyDavid A Etzioni
Department of Surgery, David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles, California, USA
Cancer 101:2523-32. 2004..Assuring that all individuals have both health insurance and a usual source of care would help address gaps in the receipt of CRC tests... - Racial differences in colorectal cancer test use by Medicare consumersAnna P Schenck
Medical Review of North Carolina, Cary, North Carolina 27511 8598, USA
Am J Prev Med 30:320-6. 2006..Lower use of colorectal cancer (CRC) screening has been suggested as a factor in higher rates of CRC incidence and mortality among African Americans. Racial differences in colorectal cancer test use are not well understood... - Patterns and predictors of colorectal cancer test use in the adult U.S. populationLaura C Seeff
Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 3717, USA
Cancer 100:2093-103. 2004..Screening is effective in reducing the incidence and mortality of colorectal cancer. Rates of colorectal cancer test use continue to be low... - In search of the perfect comorbidity measure for use with administrative claims data: does it exist?Laura Mae Baldwin
Department of Family Medicine, University of Washington, Seattle, Washington 98195 4982, USA
Med Care 44:745-53. 2006..Numerous measures of comorbidity have been developed for health services research with administrative claims... - Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyRichard M Hoffman
Medicine Service, New Mexico VA Health Care System, Albuquerque, NM 87108, USA
J Gen Intern Med 18:845-53. 2003..We examined whether there were racial differences in initial treatment for clinically localized prostate cancer and investigated whether demographic, socioeconomic, clinical, or tumor characteristics could explain any racial differences... - Communicating breast cancer risk: patient perceptions of provider discussionsRenee Royak-Schaler
University of Maryland, School of Medicine, Baltimore, USA
Medscape Womens Health 7:2. 2002..However, additional studies are needed to investigate the relationship between knowledge of breast cancer risk factors and the adoption of behaviors associated with reducing breast cancer risk... - Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screeningJennifer S Haas
Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120 1613, USA
Prev Chronic Dis 4:A90. 2007..However, another possible influence, the effect of regional differences in physicians' beliefs and recommendations on screening use, has not been assessed... - Data sources for measuring colorectal endoscopy use among Medicare enrolleesAnna P Schenck
The Carolinas Center for Medical Excellence, 100 Regency Forest, Suite 200, Cary, NC 27511 8598, USA
Cancer Epidemiol Biomarkers Prev 16:2118-27. 2007..We compared ascertainment of sigmoidoscopy and colonoscopy between three data sources: self reports, Medicare claims, and medical records... - Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology traineesAmy S Oxentenko
Mayo Clinic College of Medicine, Rochester, MN, USA
J Cancer Educ 22:219-26. 2007.... - Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for serviceAnna P Schenck
The Carolinas Center for Medical Excellence, Cary, NC 27511 8598, USA
Cancer Epidemiol Biomarkers Prev 17:799-804. 2008..Medicare claims have been used to measure CRC testing but the validity of using claims to measure fecal occult blood tests (FOBT) has not been established... - Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?Nancy L Keating
Division of General Internal Medicine and the Department of Surgery and Center for Surgery and Public Health, Brigham and Women s Hospital, USA
J Clin Oncol 26:2532-7. 2008..We surveyed cancer physicians to understand how patients' age and comorbidity influence adjuvant chemotherapy recommendations and whether physician or practice characteristics also affect these recommendations... - Data systems to evaluate colorectal cancer screening practices and outcomes at the population levelPatricia A Carney
Departments of Family Medicine and Public Health and Preventive Medicine, Oregon Health and Science University, Portland, Oregon 97239, USA
Med Care 46:S132-7. 2008 - Increasing colorectal cancer testing: translating physician interventions into population-based practiceAnna P Schenck
The Carolinas Center for Medical Excellence, Cary, NC 27511, USA
Health Care Financ Rev 27:25-35. 2006..Results in one State were stronger than the other, and two components of the intervention appeared more promising than others. Use of CRC tests can be increased, but additional approaches are needed...